Literature DB >> 20642677

Retroviral restriction factors and infectious risk in xenotransplantation.

Y Meije1, R R Tönjes, J A Fishman.   

Abstract

The clinical application of xenotransplantation poses immunologic, ethical, and microbiologic challenges. Significant progress has been made in the investigation of each of these areas. Among concerns regarding infectious risks for human xenograft recipients is the identification in swine of infectious agents including porcine endogenous retroviruses (PERV) that are capable of replication in some human cell lines. PERV replication has, however, been difficult to demonstrate in primate-derived cell lines and in preclinical studies of non-human primates receiving porcine xenografts. Endogenous 'retroviral restriction factors' are intracellular proteins and components of the innate immune system that act at various steps in retroviral replication. Recent studies suggest that some of these factors may have applications in the management of endogenous retroviruses in xenotransplantation. The risks of PERV infection and the potential role of retroviral restriction factors in xenotransplantation are reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642677      PMCID: PMC2909010          DOI: 10.1111/j.1600-6143.2010.03146.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  40 in total

1.  Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

Authors:  C A Wilson; S Wong; M VanBrocklin; M J Federspiel
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells.

Authors:  G Scheef; N Fischer; U Krach; R R Tönjes
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines.

Authors:  Armin Ritzhaupt; Luc J W Van Der Laan; Daniel R Salomon; Carolyn A Wilson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine.

Authors:  Beth A Oldmixon; James C Wood; Thomas A Ericsson; Carolyn A Wilson; Mary E White-Scharf; Goran Andersson; Julia L Greenstein; Henk-Jan Schuurman; Clive Patience
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

Authors:  Liangxue Lai; Donna Kolber-Simonds; Kwang-Wook Park; Hee-Tae Cheong; Julia L Greenstein; Gi-Sun Im; Melissa Samuel; Aaron Bonk; August Rieke; Billy N Day; Clifton N Murphy; David B Carter; Robert J Hawley; Randall S Prather
Journal:  Science       Date:  2002-01-03       Impact factor: 47.728

6.  Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells.

Authors:  Joachim Denner; Volker Specke; Ulla Thiesen; Alexander Karlas; Reinhard Kurth
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

7.  Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Authors:  Melvyn W Yap; Sébastien Nisole; Clare Lynch; Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine.

Authors:  James C Wood; Gary Quinn; Kristen M Suling; Beth A Oldmixon; Brian A Van Tine; Robert Cina; Scott Arn; Christine A Huang; Linda Scobie; David E Onions; David H Sachs; Henk-Jan Schuurman; Jay A Fishman; Clive Patience
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors.

Authors:  M Wilhelm; J A Fishman; R Pontikis; A M Aubertin; F X Wilhelm
Journal:  Cell Mol Life Sci       Date:  2002-12       Impact factor: 9.261

10.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

View more
  8 in total

Review 1.  Regulation of Clinical Xenotransplantation-Time for a Reappraisal.

Authors:  David K C Cooper; Richard N Pierson; Bernhard J Hering; Muhammad M Mohiuddin; Jay A Fishman; Joachim Denner; Curie Ahn; Agnes M Azimzadeh; Leo H Buhler; Peter J Cowan; Wayne J Hawthorne; Takaaki Kobayashi; David H Sachs
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

2.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

3.  Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases.

Authors:  Eva Dörrschuck; Nicole Fischer; Ignacio G Bravo; Kay-Martin Hanschmann; Heidi Kuiper; Andreas Spötter; Ronny Möller; Klaus Cichutek; Carsten Münk; Ralf R Tönjes
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 4.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 5.  Antiviral activity of animal venom peptides and related compounds.

Authors:  Élida Cleyse Gomes da Mata; Caroline Barbosa Farias Mourão; Marisa Rangel; Elisabeth Ferroni Schwartz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-01-06

Review 6.  Porcine Endogenous Retroviruses and Xenotransplantation, 2021.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2021-10-26       Impact factor: 5.048

7.  No evidence of viral transmission following long-term implantation of agarose encapsulated porcine islets in diabetic dogs.

Authors:  Lawrence S Gazda; Horatiu V Vinerean; Melissa A Laramore; Richard D Hall; Joseph W Carraway; Barry H Smith
Journal:  J Diabetes Res       Date:  2014-06-05       Impact factor: 4.011

Review 8.  How Active Are Porcine Endogenous Retroviruses (PERVs)?

Authors:  Joachim Denner
Journal:  Viruses       Date:  2016-08-03       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.